Board has approved recommendation of Final Dividend for the Financial Year ended 31sr March, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.3 pts less than Nifty Microcap 250 and 1.8 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
ZR2 Bioenergy Ltd's board has recommended a final dividend of Rs. 0.10 per equity share (face value Rs. 1), translating to 10%, for the financial year ended March 31, 2025, subject to shareholder approval at the upcoming 86th AGM. The record date for determining eligible shareholders has been set as September 9, 2025, and the dividend will be paid within 30 days of the AGM, after applicable tax deductions. The board also approved the appointment of a new Secretarial Auditor for five years, the re-appointment of a retiring director, shifting of the registered office from Gujarat to Maharashtra, reclassification of authorised share capital, and the launch of a new ESOP plan (ZR2 Bioenergy ESOP 2025), all pending shareholder approval.
The 10% final dividend offers a modest payout to shareholders, but the dividend yield relative to the current market price has not been disclosed. The additional proposals — registered office shift, capital reclassification, and ESOP introduction — signal structural changes that could dilute existing shareholders once the ESOP is exercised, though none require immediate action from retail investors beyond noting the September 9 record date for dividend eligibility.